Issue 4 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

29

No.

4

April 28, 2006Apr 28, 2006

Free

DOWNLOAD THE PDF

NSABP Trial Finds Raloxifene Equivalent To Tamoxifen For Cancer Risk Reduction

Celebrex Studies Show Polyp Reduction, Point To Challenges In Biomarker Validation

Benefit Of Chemotherapy Depends ER Status

WHI Update: No Increased Risk Of Cancer With Estrogen-Alone

Panitumumab Improves PFS In Metastatic Colon Cancer

NCI-Approved Trials Listed

Recent Issues

Volume 50 | Issue 17 - April 26, 2024

Volume 50 | Issue 16 - April 19, 2024

Volume 50 | Issue 15 - April 12, 2024

Volume 50 | Issue 14 - April 05, 2024

Volume 50 | Issue 13 - March 29, 2024

Volume 50 | Issue 12 - March 22, 2024